An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment
A redox-responsive supramolecular nanocarrier was constructed from the self-assembly of spermine modified cyclodextrin and oxaliplatin prodrug. The nanocarrier could preferentially accumulate in polyamine transporter over-expressing HCT116 cells, releasing drugs under a reducing intracellular enviro...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/137605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-137605 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1376052023-02-28T19:46:03Z An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment Lim, Wei Qi Phua, Fiona Soo Zeng Chen, Hongzhong Zhao, Yanli School of Physical and Mathematical Sciences Science::Chemistry Nanomedicine Nanocarrier A redox-responsive supramolecular nanocarrier was constructed from the self-assembly of spermine modified cyclodextrin and oxaliplatin prodrug. The nanocarrier could preferentially accumulate in polyamine transporter over-expressing HCT116 cells, releasing drugs under a reducing intracellular environment to maximize anticancer treatment. NRF (Natl Research Foundation, S’pore) MOE (Min. of Education, S’pore) Accepted version 2020-04-06T04:57:57Z 2020-04-06T04:57:57Z 2018 Journal Article Lim, W. Q., Phua, F. S. Z., Chen, H., & Zhao, Y. (2018). An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment. Chemical Communications, 54, 12762-12765. doi:10.1039/c8cc07858k 1359-7345 https://hdl.handle.net/10356/137605 10.1039/c8cc07858k 54 12762 12765 en Chemical Communications © 2018 The Author(s) (Royal Society of Chemistry). All rights reserved. This paper was published in Chemical Communications and is made available with permission of The Author(s) (Royal Society of Chemistry). application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Chemistry Nanomedicine Nanocarrier |
spellingShingle |
Science::Chemistry Nanomedicine Nanocarrier Lim, Wei Qi Phua, Fiona Soo Zeng Chen, Hongzhong Zhao, Yanli An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
description |
A redox-responsive supramolecular nanocarrier was constructed from the self-assembly of spermine modified cyclodextrin and oxaliplatin prodrug. The nanocarrier could preferentially accumulate in polyamine transporter over-expressing HCT116 cells, releasing drugs under a reducing intracellular environment to maximize anticancer treatment. |
author2 |
School of Physical and Mathematical Sciences |
author_facet |
School of Physical and Mathematical Sciences Lim, Wei Qi Phua, Fiona Soo Zeng Chen, Hongzhong Zhao, Yanli |
format |
Article |
author |
Lim, Wei Qi Phua, Fiona Soo Zeng Chen, Hongzhong Zhao, Yanli |
author_sort |
Lim, Wei Qi |
title |
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
title_short |
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
title_full |
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
title_fullStr |
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
title_full_unstemmed |
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
title_sort |
oxaliplatin(iv) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment |
publishDate |
2020 |
url |
https://hdl.handle.net/10356/137605 |
_version_ |
1759854973709975552 |